On August 12, it was announced that Israel-based Taro Pharmaceutical Industries Ltd. has accepted an improved buyout offer from India-based Sun Pharmaceutical Industries Ltd., Taro’s majority shareholder. The merger agreement was approved by Taro’s Board of Directors, based upon the recommendations and approvals of its Special Committee, represented by Willkie, and its Audit Committee.

More >>

The Firm recently represented the underwriters, led by Citigroup, Deutsche Bank and J.P. Morgan, in connection with a public offering by Altria Group, Inc. of $1.9 billion aggregate principal amount of its 2.850% Notes due 2022 and $900 million aggregate principal amount of its 4.250% Notes due 2042. The offering closed on August 9, 2012.

More >>

Antitrust Litigation Partner Paul Kaplan has joined Locke Lord’s New York office as part of the Firm’s Litigation Department and Antitrust Practice Group. He brings more than 25 years of experience in handling litigation and counseling for major corporations as well as for domestic and international financial institutions. His significant background and experience in antitrust matters across numerous industries will strengthen the national platform of the Firm’s Antitrust Practice.

More >>

International law firm Milbank, Tweed, Hadley & McCloy LLP, led by Global Securities partner Rob Williams, represented J.P. Morgan, RBS, Wells Fargo Securities and a syndicate of ten other underwriters in connection with the registered public offering by BRE Properties, Inc. (“BRE”) of $300 million 3.375% Senior Notes due 2023.

More >>

Kelley Drye & Warren LLP is pleased to announce that Andrew J. Green, a real estate attorney, has joined the firm as a partner, resident in the New York office.  Mr. Green was previously a partner at Rosenman & Colin LLP (now the firm of Katten Muchin Rosenman LLP), then partner and of counsel at Jones Day.

More >>

Cahill represented BofA Merrill Lynch, J.P. Morgan, Rabo Securities, Barclays, and Wells Fargo Securities as joint book-running managers and the co-managers in connection with the public offering of $650,000,000 principal amount of 4.625% Senior Notes due 2023 by Constellation Brands, Inc.

More >>

Cahill represented Citigroup, Deutsche Bank Securities, J.P. Morgan, Nomura, and Wells Fargo Securities as joint book-running managers and the co-managers in connection with the Rule 144A/Reg S offering of $350,000,000 7.75% Senior Notes due 2022 by EP Energy LLC. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.

More >>

Davis Polk advised PepsiCo, Inc. on its registered offering of $900 million aggregate principal amount of 0.7% senior notes due 2015, $1 billion aggregate principal amount of 1.25% senior notes due 2017 and $600 million aggregate principal amount of 3.6% senior notes due 2042. Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and RBS Securities Inc. acted as joint book-running managers for the offering.

More >>

Simpson Thacher is representing affiliates of The Carlyle Group in connection with their acquisition of The TCW Group, Inc. (“TCW”) from Société Générale. Founded in 1971, TCW is a Los Angeles-based diversified asset management firm offering U.S. equities and fixed income, international and alternative strategies, with approximately $130 billion under management. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2013. Financial terms were not disclosed.

More >>

Shearman & Sterling is advising Sun Pharmaceutical Industries Ltd. (Sun Pharma) on its merger agreement with Taro Pharmaceutical Industries Ltd. (Taro). Upon completion of the merger, Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma, and its ordinary shares will no longer be traded on the New York Stock Exchange. The closing of the merger is subject to certain terms and conditions customary for transactions of this type.

More >>